Several lines of evidence suggest that immunisations may be helpful in the prophylaxis and treatment of neurodegenerative amyloidoses like Alzheimer's disease and prion infections. We used a synthetic prion protein-derived peptide (PrP105-125) and a recombinant PrP fragment (PrP90-230) as antigens for the active immunisation of mice, which were subsequently infected by dietary exposure to the scrapie agent. Immunisation with PrP105-125 prolonged the survival times significantly. In contrast, immunisation with PrP90-230 or adjuvants alone had no effect on the disease development. An epitope mapping of the antibodies raised against PrP90-230 revealed that reactivities against previously defined protective epitopes were either underrepresented or absent. These results point towards the possibility to prevent prion spread via the food chain by vaccinating humans or other species at risk to contract prion diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0304-3940(03)00907-8DOI Listing

Publication Analysis

Top Keywords

synthetic prion
8
prion protein-derived
8
protein-derived peptide
8
survival times
8
scrapie agent
8
prion
5
immunisation
4
immunisation synthetic
4
peptide prolongs
4
prolongs survival
4

Similar Publications

Background: Paper symptom diaries are a common tool for assessing motor fluctuations in Parkinson's disease (PD) patients, but there are concerns about inaccuracies in the assessment of motor fluctuation due to recall bias and poor compliance. We, therefore, developed an electronic diary with reminder and real-time recording functions.

Objectives And Methods: To evaluate the effectiveness of the electronic diary, we compared compliance and motor fluctuation assessment with a paper diary.

View Article and Find Full Text PDF

[PSI]-CIC: A Deep-Learning Pipeline for the Annotation of Sectored Saccharomyces cerevisiae Colonies.

Bull Math Biol

December 2024

Department of Applied Mathematics, University of California, Merced, 5200 N Lake Drive, Merced, CA, 95343, USA.

The prion phenotype in yeast manifests as a white, pink, or red color pigment. Experimental manipulations destabilize prion phenotypes, and allow colonies to exhibit (red) sectored phenotypes within otherwise completely white colonies. Further investigation of the size and frequency of sectors that emerge as a result of experimental manipulation is capable of providing critical information on mechanisms of prion curing, but we lack a way to reliably extract this information.

View Article and Find Full Text PDF
Article Synopsis
  • Mammalian prions are infectious proteins formed from misfolded variants of the normal prion protein (PrP), exhibiting different conformations that can self-propagate and cause various prion diseases.
  • Research demonstrates that fibrillar assemblies from recombinant PrP (rPrP) derived from various species (hamster, mouse, human, and bovine) show distinct pathogenic behaviors and strain properties when tested in transgenic mice.
  • The findings indicate that rPrP assemblies can be used to study the transmission of prions and their strain diversity, as they can mimic the adaptation processes of genuine prions despite lacking certain crucial amino acid regions for infectivity.
View Article and Find Full Text PDF

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by amyloid plaques and cognitive decline, the latter of which is thought to be driven by soluble oligomeric amyloid-β (oAβ). The dysregulation of G protein-gated inwardly rectifying K (GIRK; also known as Kir3) channels has been implicated in rodent models of AD. Here, seeking mechanistic insights, we uncovered a sex-dependent facet of GIRK-dependent signaling in AD-related amyloid pathophysiology.

View Article and Find Full Text PDF

Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research.

Front Immunol

September 2024

Minnesota Center for Prion Research and Outreach (MNPRO), University of Minnesota, St. Paul, MN, United States.

Neurodegenerative diseases (NDs) in mammals, such as Alzheimer's disease (AD), Parkinson's disease (PD), and transmissible spongiform encephalopathies (TSEs), are characterized by the accumulation of misfolded proteins in the central nervous system (CNS). Despite the presence of these pathogenic proteins, the immune response in affected individuals remains notably muted. Traditional immunological strategies, particularly those reliant on monoclonal antibodies (mAbs), face challenges related to tissue penetration, blood-brain barrier (BBB) crossing, and maintaining protein stability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!